Nav: Home

Physician breast cancer screening recommendations amid changing guidelines

April 10, 2017

Disagreement persists between professional societies and organizations over the best time to start and to discontinue mammography for breast cancer screening, as well as the optimal amount of time between screenings. A new research letter published by JAMA Internal Medicine examines breast cancer screening recommendations physicians give their patients amid recent guideline changes.

For example, the American Cancer Society (ACS) revised its guidelines in 2015 to encourage personalized screening decisions for women 40 to 44 followed by annual screening starting at age 45 and biennial screening for women 55 or older. The U.S. Preventive Services Task Force (USPSTF) reissued its recommendations in 2016 to recommend personalized screening decisions for women 40 to 49 followed by biennial mammograms for women 50 to 74. The American Congress of Obstetricians and Gynecologists (ACOG) recommends yearly mammograms for women 40 and older.

Archana Radhakrishnan, M.D., M.H.S., of Johns Hopkins University, Baltimore, Md., and coauthors examined physician screening recommendations in a national sample of physicians with a 52 percent response rate among eligible participants (871 of 1,665 physicians). Most of the physicians were family medicine/general practice physicians (44.2 percent), almost 30 percent were internal medicine physicians and 26.1 percent were gynecologists.

Overall, 81 percent of physicians recommended screening to women 40 to 44; 88 percent to women 45 to 49; and 67 percent for women 75 or older. Gynecologists were more likely to recommend screening for women of all ages compared with internal medicine and family medicine/general practice physicians. Among clinicians who recommend screening, most recommend annual examinations, according to the results.

Among the physicians, 26 percent reported trusting ACOG guidelines the most; 23.8 percent the ACS guidelines and 22.9 percent the USPSTF guidelines.

"The results provide an important benchmark as guidelines continue evolving and underscore the need to delineate barriers and facilitators to implementing guidelines in clinical practical," the article concludes.
-end-
(JAMA Intern Med. Published online April 10, 2017. doi:10.1001/jamainternmed.2017.0453; available pre-embargo at the For The Media website.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Related material: The editorial, "Physician Adherence to Breast Cancer Screening Recommendations," by Deborah Grady, M.D., M.P.H., and Rita F. Redberg, M.D., M.Sc., of the University of California, San Francisco, also is available on the For The Media website.

To place an electronic embedded link in your story: Links will be live at the embargo time: http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2017.0453

The JAMA Network Journals

Related Breast Cancer Screening Articles:

Screening mammography could benefit men at high risk of breast cancer
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a new landmark study.
Bundle payment model analysis of emerging breast cancer screening
Bundled payments have been touted as mechanisms to optimize quality and costs.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
Breast cancer screening does not reduce mortality
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the age groups that are not screened.
Is prognosis poor for breast cancer diagnosed after negative screening mammography?
A study of mammography data for more than 300,000 women suggests cases of breast cancer diagnosed after a negative screening mammogram were more likely to be associated with poor prognosis than those cancers diagnosed after a positive screening mammogram.
Making individualized choices about breast cancer screening
The authors note, that despite the fact that the United States Preventive Services Task Force (USPSTF) changed its recommendation in 2009 to mammograms every two years for women aged 50-74 instead of annual mammograms beginning at age 40, there has been little change in US screening practices.
Why are women at high breast cancer risk not having supplemental MRI screening?
Women at high lifetime breast cancer risk might benefit from breast MRI screening in addition to routine mammography, but a new study shows that breast MRI is greatly underutilized even though access is widely available.
Community practices not following guidelines for MRI breast cancer screening
Guidelines are not being followed to ensure that breast cancer screening of high risk women, such as those with a strong family history of breast cancer, includes an additional MRI (magnetic resonance imaging) scan.
Screening has had 'little impact' on falling breast cancer deaths in the Netherlands
Breast screening in the Netherlands seems to have had a marginal effect on breast cancer mortality over the past 24 years, suggests research in The BMJ today.
Physicians' experiences with family and friends impact breast cancer screening
Results of a national survey of more than 800 physicians suggest that their experiences with patients, family members and friends with breast cancer are linked with their recommendations for routine mammograms.
More Breast Cancer Screening News and Breast Cancer Screening Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.